文献速递肾小球疾病

多重反应监测质谱法多重检测膜性肾病抗原

Multiplexed Detection of Membranous Nephropathy Antigens by Multi-Reaction Monitoring Mass Spectrometry.
PubMed 文献 · Kidney Int Rep · 2026-04-22

本研究开发了基于多重反应监测(MRM)的质谱检测方法,用于肾活检组织中膜性肾病(MN)抗原的多重分型。该方法可定量检测19种MN抗原,在113例经免疫组化确认抗原类型的验证队列中,诊断准确率97.2%,敏感性97.2%,特异性100%。

要点

  • MRM质谱法可同时检测19种膜性肾病靶抗原。
  • 验证队列诊断准确率97.2%,敏感性97.2%,特异性100%。
  • 为肾病理临床实践提供多重抗原分型新工具。

核心结论

  • 蛋白A/G免疫沉淀联合MRM质谱可有效用于膜性肾病活检组织的多重抗原分型。

研究设计与样本

  • 方法学研究,采用蛋白A/G免疫沉淀从冷冻肾活检组织提取免疫复合物,经单管固相增强样品制备流程酶解,用内标肽段进行MRM质谱定量,以峰面积比判定抗原类型,免疫组化作为独立确认方法,验证队列为113例经免疫组化确认抗原类型的MN病例。

主要发现

  • 该免疫沉淀-质谱流程可可靠定量检测总共19种MN抗原。
  • 在113例验证队列中,诊断准确率97.2%,敏感性97.2%,特异性100%。

关键数值与推荐

  • 以峰面积比判定抗原类型,并经验性开发了判定算法以最大化敏感性和特异性。
  • 验证队列113例MN病例的抗原类型均由免疫组化确认。

临床怎么用

  • 可在临床肾病理实验室开展,用于膜性肾病活检组织的多重抗原分型,辅助诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Membranous nephropathy (MN) is a leading cause of nephrotic syndrome, driven by an immune response against a target autoantigen. To date, over 30 target antigens have been described in MN, creating the need for multiplex approaches. We developed a multiple reaction monitoring (MRM)-based assay for the clinical mass spectrometry (MS) laboratory for determination of an antigen type in nephropathology practice. Here, we provide detailed methods and validation data to ensure adaptability among different instruments and laboratories. METHODS: Protein A/G immunoprecipitation was used to extract immune complexes from frozen kidney biopsy tissue. Proteins were eluted from magnetic beads, reduced, alkylated, and trypsin digested using single-pot, solid-phase-enhanced sample preparation workflow. Tryptic peptide quantities were measured by MS with internal standard (IS) peptides. Peak area ratios were used to call an antigen type. Immunostaining was used as an independent method to confirm target antigen types. A calling algorithm was empirically developed that maximizes sensitivity and specificity of the workflow for identifying membranous antigens in kidney biopsies. RESULTS: Our immunoprecipitation-to-MS workflow demonstrated reliable quantitative detection of a total of 19 MN antigens. The MS-enabled workflow had a diagnostic accuracy of 97.2% with a sensitivity of 97.2% and 100% specificity from a validation cohort of 113 MN cases with antigen type confirmed by immunostaining. CONCLUSION: MRM-MS following protein A/G immunoprecipitation of MN biopsy tissue can be effectively used for multiplex antigen typing in clinical nephropathology practice.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Storey AJ, Caza TN, Hassen SI, et al. Multiplexed Detection of Membranous Nephropathy Antigens by Multi-Reaction Monitoring Mass Spectrometry. Kidney Int Rep. 2026. PMID: 42254855. doi:10.1016/j.ekir.2026.106561

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。